These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8140040)

  • 21. Controlled release by permeability alteration of cationic ammonio methacrylate copolymers using ionic interactions.
    Ravishankar H; Patil P; Samel A; Petereit HU; Lizio R
    Drug Dev Ind Pharm; 2006 Jul; 32(6):709-18. PubMed ID: 16885126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
    Sauer D; McGinity J
    Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions.
    Tang X; Tai LY; Yang XG; Chen F; Xu HM; Pan WS
    Drug Dev Ind Pharm; 2013 Jan; 39(1):67-76. PubMed ID: 22339718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
    Kadam VD; Gattani SG
    Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and optimization of colon-targeted system of theophylline for chronotherapy of nocturnal asthma.
    Patel MM; Amin AF
    J Pharm Sci; 2011 May; 100(5):1760-72. PubMed ID: 21154966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of in vivo drug release behavior of controlled-release multiple-unit dosage forms in dogs using a flow-through type dissolution test method.
    Ikegami K; Tagawa K; Kobayashi M; Osawa T
    Int J Pharm; 2003 Jun; 258(1-2):31-43. PubMed ID: 12753751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique.
    Jelvehgari M; Barar J; Valizadeh H; Shadrou S; Nokhodchi A
    Pharm Dev Technol; 2011; 16(6):637-44. PubMed ID: 20722498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel sustained-release fast-disintegrating multi-unit compressed tablets of lornoxicam containing Eudragit RS coated chitosan-alginate beads.
    Aburahma MH; Hamza Yel-S
    Pharm Dev Technol; 2011 Aug; 16(4):316-30. PubMed ID: 20307250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of in vitro and in vivo dissolution of theophylline from film-coated pellets.
    Muskó Z; Pintye-Hódi K; Gáspár R; Pintye J; Szabó-Révész P; Eros I; Falkay G
    Eur J Pharm Biopharm; 2001 Mar; 51(2):143-6. PubMed ID: 11226821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery.
    Ali Asghar LF; Azeemuddin M; Jain V; Chandran S
    Drug Deliv; 2009 Aug; 16(6):295-303. PubMed ID: 19606943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organic solution versus aqueous dispersion of Eudragit RS in preparation of sustained release microparticles of theophylline using spray drying.
    Garekani HA; Moghaddam ZF; Sadeghi F
    Colloids Surf B Biointerfaces; 2013 Aug; 108():374-9. PubMed ID: 23602991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technology to obtain sustained release characteristics of drugs after delivered to the colon.
    Hu Z; Kimura G; Ito Y; Mawatari S; Shimokawa T; Yoshikawa H; Yoshikawa Y; Takada K
    J Drug Target; 1999; 6(6):439-48. PubMed ID: 10937289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
    Terebesi I; Bodmeier R
    Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
    Speer I; Preis M; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of ibuprofen as a solid-state plasticizer in Eudragit RS 30 D on the physicochemical properties of coated beads.
    Wu C; McGinity JW
    AAPS PharmSciTech; 2001 Nov; 2(4):24. PubMed ID: 14727861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets.
    Gao C; Huang J; Jiao Y; Shan L; Liu Y; Li Y; Mei X
    Int J Pharm; 2006 Sep; 322(1-2):104-12. PubMed ID: 16806752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique.
    Sungthongjeen S; Paeratakul O; Limmatvapirat S; Puttipipatkhachorn S
    Int J Pharm; 2006 Nov; 324(2):136-43. PubMed ID: 16828997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time- and pH-dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid.
    Cheng G; An F; Zou MJ; Sun J; Hao XH; He YX
    World J Gastroenterol; 2004 Jun; 10(12):1769-74. PubMed ID: 15188503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.